Inspections, Compliance, Enforcement, and Criminal Investigations

January 20, 2011: Dietary Supplements Manufacturer Pleads Guilty

OCI Small Clear Seal

Food and Drug Administration
Office of Criminal Investigations

U.S. Department of Justice Press Release


For Immediate Release
January 20, 2011

United States Attorney
District of Idaho
Contact: Pamela Bearg
Public Information Officer
(208) 334-1211


Tribravus Enterprises, LLC, dba IForce Nutrition, pled guilty today in federal court to causing purported dietary supplements to be unlawfully manufactured and distributed in interstate commerce, the U.S. Attorney's Office announced. According to the plea agreement, the products, called “17aPheraFLEX,” “Dymethazine” and “Methadrol,” contained synthetic steroids and were unapproved drugs under the Food, Drug and Cosmetic Act.

The charge, which carries a maximum fine of $500,000, is a felony because the defendant acted with the intent to defraud or mislead. According to the plea agreement, the parties have agreed to recommend that the defendant pay a $125,000 fine. Also as part of the plea, Tribravus has agreed to implement a testing protocol for its products to ensure future products sold as dietary supplements do not contain synthetic steroids.

Tribravus Enterprises is organized in Arizona and does business as IForce Nutrition in Vista, California. The charges were brought in federal court in Idaho because Tribravus delivered its products to a retail company located in Idaho for further distribution throughout the United States.

The case was investigated by the Food and Drug Administration, Office of Criminal Investigations.

Sentencing is set for April 20, 2011, in Boise before Chief United States District Judge B. Lynn Winmill.

# # #

Page Last Updated: 01/28/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English